FDA Announces Proposed Collection of Information for Review and Clearance Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in order to develop guidance for industry and FDA staff on the Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle.